Is bromantane better than modafinil?

It depends which problem you have. Bromantane scores 7.1 against modafinil's 5.9, but that margin comes from a lighter side-effect profile and better durability rather than better evidence. Modafinil wins energy 7.0 to 6.2, cognition 6.5 to 5.8 and memory 5.5 to 3.5. Bromantane wins stress resilience 6.0 to 3.0, anxiety 5.7 to 3.5 and sleep quality 4.0 to 1.5.

Has anyone run a study comparing bromantane and modafinil?

No. Neither source report carries a direct comparison of the two, so every verdict on this page is assembled from separate evidence bases. Those bases are not equal in size. Modafinil has systematic reviews, a 2026 meta-analysis in 997 narcolepsy patients and an FDA label. Bromantane has one placebo-controlled RCT, one open-label trial in 728 patients, about 30 Russian preclinical papers, and zero Western RCTs.

How fast does each one work?

Modafinil gives a first effect at about 1 hour and full effect at about 3 hours, against a 2-week assessment window. Bromantane gives a first lift at about 2 hours but needs about 2 weeks to reach full effect, against a 4-week window. That difference decides which one suits a single hard day and which one suits a course.

Which one is safer, bromantane or modafinil?

Bromantane scores 1.8 on safety risk against modafinil's 4.0, and it looks cleaner in the data that exists. Voznesenskaia 2010 recorded 3 percent adverse events across 728 patients. The catch is that human safety data stops at 28 days, so the clean record is also a short one. Modafinil's risks are documented precisely because the drug has been studied: serious rash, hypersensitivity, psychiatric symptoms and cardiovascular cautions all sit on the FDA label.

Can I take bromantane and modafinil together?

Nothing in either report supports it. Both act on the dopamine transporter, and the bromantane report explicitly lists modafinil among the dopaminergics to use caution with, alongside methylphenidate, amphetamines, L-DOPA and selegiline. There is no combination data on either side. Run one, judge it inside its own window, then decide.

Which one is cheaper?

Neither, in any way that should sway you. Bromantane runs an estimated $12 to $30 a month at 30 mg on about 10 mornings, and modafinil an estimated $18 to $35 a month for generic 200 mg tablets with a coupon. Both are estimates priced 2026-09-07. Modafinil adds a prescribing visit, bromantane adds a third-party HPLC assay.

Can I compete in tested sport on either one?

No. Bromantane has been on the WADA prohibited list under S6.A stimulants every year since 1997, and Western awareness of the compound arrived through the Atlanta 1996 doping cases documented in Burnat 1997. Modafinil is prohibited in competition under the same S6.A category. Both reports list tested sport as a contraindication.

Who should avoid these?

Both rule out pregnancy and lactation, and bromantane adds an age floor of 18, MAOI co-administration, bipolar I disorder and uncontrolled hypertension. Modafinil rules out a history of serious drug rash, mania or psychosis, uncontrolled anxiety, arrhythmia or significant cardiovascular disease, left ventricular hypertrophy, mitral valve prolapse, uncontrolled hypertension and severe hepatic impairment, and it needs backup contraception alongside hormonal birth control.

Head-to-Head Comparison

Bromantane vs Modafinil: Which Is Better for Focus?

Should I take bromantane or modafinil?

Reviewed 09/07/2026

Bromantane scores 7.1 and modafinil 5.9, and they answer different questions. Modafinil is the faster and better-documented wakefulness drug when sleep debt or diagnosed sleepiness is the problem. Bromantane is the calmer option for fatigue and stress load, with one Russian trial base, no Western replication, and a gray-market supply chain.

Bromantane 7.1, modafinil 5.9. The gap comes from side effects and durability, not from a bigger evidence base.
Modafinil wins the wakefulness rows: energy 7.0 against 6.2, cognition 6.5 against 5.8, memory 5.5 against 3.5.
Bromantane wins stress resilience 6.0 against 3.0, anxiety 5.7 against 3.5, and sleep quality 4.0 against 1.5.
Modafinil works in about an hour and reaches full effect in three. Bromantane takes about two hours for a lift and two weeks for the full picture.
Modafinil is a Schedule IV prescription. Bromantane has had no Western retail channel since Ladasten was discontinued in 2018, so an HPLC certificate is part of the real cost.
Both sit on the WADA prohibited list. Bromantane has been there since 1997, and modafinil is prohibited in competition under S6.A.

At a Glance

Option B

Modafinil

5.9 / 10 Worth trying

Upside

Efficacy 4.5
Breadth 3.6
Evidence 4.3
Speed 4.5
Durability 1.5
Bioindividuality 3.4

Downside

Safety Risk 4.0
Side Effects 2.6
Cost 2.5
Effort 1.3
Opportunity Cost 2.5
Dependency 2.0
Reversibility 1.5

Best at:

Energy 7.0
Cognition Focus 6.5
Reaction Time 6.5
Mood 5.5

Schedule IV prescription eugeroic for diagnosed sleepiness. BioHarmony 5.9, worth trying.

Read full BioHarmony report →

Head-to-Head Verdict

Use Case	Winner	Rationale
Energy	Modafinil	Modafinil 7.0 against bromantane's 6.2, and the trial settings decide it. Caldwell 2000 and Caldwell 2004 tested pilots in helicopter simulators through sleep deprivation and 37 hours without sleep, and modafinil held performance and alertness where placebo fell away. Bromantane's energy case rests on Morozov 1998, which measured physical work capacity in mice and rats.
Cognition Focus	Modafinil	Modafinil 6.5 against 5.8. Battleday 2015 reviewed healthy non-sleep-deprived subjects and found cautious support for complex attention, executive function and learning, with the caveat that the domains were inconsistent. Bromantane has one Western-journal mechanism paper (Mikhaylova 2007, rats) and no human cognition trial in its record.
Memory	Modafinil	Modafinil 5.5 against 3.5, the widest cognitive gap here. The Battleday 2015 review covers learning and memory endpoints in healthy volunteers, and Muller 2013 adds a mixed profile in the same population. Bromantane's memory case is a hippocampal LTP finding in rats that depends on D1 and D5 receptors, which is a mechanism rather than a result.
Stress Resilience	Bromantane (Ladasten)	Bromantane 6.0 against 3.0, and this is the row it was built for. Voznesenskaia 2010 treated 728 outpatients with asthenic disorders at 50 to 100 mg a day for 28 days and reported a 76.0 percent CGI-S responder rate with 3 percent adverse events. Oliynyk 2012 frames the actoprotector class as protection against heat, hypoxia and fatigue.
Anxiety	Bromantane (Ladasten)	Bromantane 5.7 against 3.5. Neznamov 2008 stratified neurasthenia patients by baseline EEG alpha and found the drug acts as a psychostimulant in one group and an anxiolytic in the other, which is the mechanism behind the score. Modafinil lists uncontrolled anxiety as a contraindication, and Jung 2026 found anxiety among its indication-dependent adverse-effect signals.
Sleep Quality	Bromantane (Ladasten)	Bromantane 4.0 against 1.5, the widest gap in the matrix. Modafinil's own report says morning dosing can disrupt that night's sleep, and Neznamov 2009 ran bromantane for 28 days plus a one-week washout with no withdrawal syndrome. Neither result is a sleep trial, so read this as which one hurts sleep less.
Mood	Tie	Both score 5.5, and neither has a mood outcome in humans that stands up. Tallerova 2011 is a mouse depression-like model where bromantane beat imipramine on TNF-alpha and IL-6. Caldwell 2004 tracked mood in pilots during 37 hours without sleep, which measures a deprivation state rather than baseline mood.
Depression	Tie	Modafinil's subrating is 5.0 against bromantane's 3.5, and no human depression trial exists on either side. Cochrane 2019 pooled 11 small modafinil trials in schizophrenia at low or very low quality with no clear difference, and Petry 2026 found no significant improvement in post-stroke fatigue across 1,001 participants. Neither number is earned.
Creativity	Tie	Both score 3.0, and this is the one row where the modafinil evidence argues against use. Muller 2013 tested non-verbal cognition, task enjoyment and creative thinking in healthy volunteers and found a creativity trade-off rather than uniform enhancement. Bromantane has nothing here at all.

Cost Comparison

Intervention	Monthly Cost	Notes
Bromantane	$12 to $30	ESTIMATE, priced 2026-09-07, research-chemical channel. Bulk powder runs $40 to $100 a gram per the report, and a 30 mg dose taken about 10 mornings a month consumes 0.3 g.The sticker price hides the real one. There is no Western retail channel and the report requires an HPLC certificate of analysis, so a third-party assay belongs in your budget alongside the powder.
Modafinil	$18 to $35	ESTIMATE, priced 2026-09-07, retail pharmacy channel. Generic modafinil 200 mg by 30 tablets runs $18 to $35 a month cash at major US chains with a discount coupon.The prescribing visit sits on top of that and is not in the figure. Overseas gray-market pharmacies undercut the price and add counterfeit, purity and legal risk in exchange.
The difference	Roughly $6 a month apart, which is not the real difference	$12 to $30 against $18 to $35. Both figures are estimates rather than measured prices, and the overlap is wide enough that neither is cheaper in any meaningful sense.What separates them is the cost around the molecule. Modafinil adds a prescribing visit. Bromantane adds a third-party HPLC assay, and Vanhee 2025 found bromantane in illicit nootropic samples with one unit at 33.2 mg, which is why the assay is not optional.

When to Switch

These two run on different clocks, and that is the first thing to get right. Modafinil gives a first effect at about 1 hour, full effect at about 3 hours, and its assessment window is 2 weeks, so you judge it on single days. Bromantane gives a first lift at about 2 hours but takes about 2 weeks to reach full effect, against a 4-week assessment window, so judging it on one morning tells you almost nothing.

Move from modafinil to bromantane when the problem is a fatigue and stress load that sits under everything rather than a specific day you have to stay awake through, when modafinil's sleep disruption is costing you more than the wakefulness is buying, or when anxiety is the side effect that keeps ending the experiment. Move the other way, from bromantane to modafinil, when you have diagnosed narcolepsy, idiopathic hypersomnia or residual sleepiness after airway treatment, because those are the indications the AASM 2021 guideline covers and bromantane has no claim on them.

Cost is not a reason to switch either way, since the two bands overlap. Do not run them together: both act on the dopamine transporter, the bromantane report lists modafinil among the dopaminergics to be cautious with, and neither report has data on the combination.

Who Should Pick What?

Diagnosed narcolepsy, idiopathic hypersomnia, or residual sleepiness after airway treatment

Modafinil

The AASM 2021 guideline makes a strong recommendation for modafinil in adult narcolepsy and adult idiopathic hypersomnia, and Mann 2026 pooled five studies in 997 patients with a maintenance-of-wakefulness gain of 3.56 minutes and an Epworth drop of 3.34. Bromantane has no claim on this population.

Knowledge worker with a chronic fatigue and stress load rather than a sleep problem

Bromantane (Ladasten)

Stress resilience 6.0 against 3.0 and anxiety 5.7 against 3.5. Voznesenskaia 2010 treated 728 outpatients with asthenic disorders for 28 days and the benefit persisted at least a month after the course ended. Give it the full 4-week window before deciding.

One hard travel day or a night of terrible sleep to recover from

Modafinil

Full effect in about 3 hours against about 2 weeks. Caldwell 2000 and 2004 both tested exactly this scenario in sleep-deprived pilots. Bromantane cannot be deployed as a single-day rescue because its own onset numbers say the effect builds.

You need to protect your sleep while raising daytime output

Bromantane (Ladasten)

Sleep quality 4.0 against 1.5. Modafinil's report says morning dosing can disrupt that night's sleep, and insomnia is one of the adverse-effect signals Jung 2026 found across 54 studies. Bromantane still needs morning dosing given its 11.2 hour half-life.

Creative or ideation-heavy work rather than narrow execution

Tie

Neither. Both score 3.0 on creativity, and Muller 2013 found modafinil produced a creativity trade-off rather than uniform enhancement in healthy volunteers. Bromantane has no creativity data at all. Nothing here earns a place in ideation work.

You compete in tested sport

Tie

Neither, and this is not a close call. Bromantane has been on the WADA prohibited list under S6.A stimulants every year since 1997, and Western awareness of it came through the Atlanta 1996 doping cases. Modafinil is prohibited in competition under the same S6.A category.

Pregnant, planning conception, or under 18

Tie

Neither. Both reports list pregnancy and lactation as contraindications, and bromantane adds an age floor of 18. Modafinil also reduces the effectiveness of steroidal contraceptives through CYP3A4 induction, so backup contraception is required during use and after stopping.

You will not source from a gray market

Modafinil

Then the choice is made for you. Bromantane has had no Western retail channel since 2018, and the report treats a product with no HPLC certificate of analysis as a contraindication. Modafinil comes through a pharmacy with identity and purity handled.

Research Highlights

Mechanism Difference
These two are complementary in mechanism and still should not be combined. Bromantane works upstream: it induces tyrosine hydroxylase gene expression by demethylating the TH promoter (Vakhitova 2006), then adds weak dopamine-reuptake inhibition and BDNF and NGF upregulation (Salimgareeva 2012). It raises the capacity to make dopamine.Modafinil works at the circuit level. Volkow 2009 confirmed dopamine transporter effects in the human brain, and the wake-promoting result runs through orexin, histamine and glutamate. Different nodes, but both touch the dopamine transporter, and the bromantane report lists modafinil among the dopaminergics to be cautious with.
Safety Comparison
Modafinil carries the heavier risk. Its safety dimension scores 4.0 against bromantane's 1.8, and the FDA label covers rare serious rash including Stevens-Johnson syndrome and toxic epidermal necrolysis, multi-organ hypersensitivity, psychiatric symptoms and cardiovascular cautions. Jung 2026 pooled 54 studies and found the adverse-effect signals differ by indication.Bromantane's problem is the opposite one: nothing to report and nothing to rely on. Voznesenskaia 2010 recorded 3 percent adverse events and 0.8 percent discontinuation in 728 patients, but human safety data stops at 28 days. Iezhitsa 2000 ran a 2-month course in rats with recovery inside 2 months.
Cost Comparison
Bromantane runs an estimated $12 to $30 a month at a 30 mg dose taken about 10 mornings, drawn from bulk powder at $40 to $100 a gram. Modafinil runs an estimated $18 to $35 a month for generic 200 mg tablets with a discount coupon. Both figures are estimates priced 2026-09-07, and the bands overlap.The costs that actually differ sit outside the price. Modafinil needs a prescribing visit. Bromantane needs a third-party HPLC certificate, which the report treats as mandatory rather than prudent, because Vanhee 2025 found it in illicit nootropic samples with one unit dosed at 33.2 mg.
Editorial Verdict
No head-to-head trial of these two exists. Nothing in either report's citation record compares them directly, so every row in this comparison is built from separate evidence bases, and the bromantane base is one Russian institutional consortium with zero Western RCTs.Take modafinil when the problem is staying awake on a specific day or a diagnosed sleepiness disorder, where Caldwell 2000, Caldwell 2004 and the AASM 2021 guideline apply. Take bromantane when the problem is a fatigue and stress load, where Voznesenskaia 2010 treated 728 patients over 28 days.
Durability
Bromantane holds an effect after the course and modafinil does not. Its durability dimension scores 3.9 against modafinil's 1.5, and Voznesenskaia 2010 reported therapeutic benefit persisting at least a month after the 28-day course ended. Neznamov 2009 added a one-week washout with no withdrawal syndrome.Modafinil is a same-day tool by design. First effect at about 1 hour, full effect at about 3, and nothing carries over. Its dependency dimension scores 2.0 against bromantane's 1.4, in line with its Schedule IV status.

Frequently Asked Questions

Is bromantane better than modafinil?: It depends which problem you have. Bromantane scores 7.1 against modafinil's 5.9, but that margin comes from a lighter side-effect profile and better durability rather than better evidence. Modafinil wins energy 7.0 to 6.2, cognition 6.5 to 5.8 and memory 5.5 to 3.5. Bromantane wins stress resilience 6.0 to 3.0, anxiety 5.7 to 3.5 and sleep quality 4.0 to 1.5.
Has anyone run a study comparing bromantane and modafinil?: No. Neither source report carries a direct comparison of the two, so every verdict on this page is assembled from separate evidence bases.Those bases are not equal in size. Modafinil has systematic reviews, a 2026 meta-analysis in 997 narcolepsy patients and an FDA label. Bromantane has one placebo-controlled RCT, one open-label trial in 728 patients, about 30 Russian preclinical papers, and zero Western RCTs.
How fast does each one work?: Modafinil gives a first effect at about 1 hour and full effect at about 3 hours, against a 2-week assessment window. Bromantane gives a first lift at about 2 hours but needs about 2 weeks to reach full effect, against a 4-week window. That difference decides which one suits a single hard day and which one suits a course.
Which one is safer, bromantane or modafinil?: Bromantane scores 1.8 on safety risk against modafinil's 4.0, and it looks cleaner in the data that exists. Voznesenskaia 2010 recorded 3 percent adverse events across 728 patients.The catch is that human safety data stops at 28 days, so the clean record is also a short one. Modafinil's risks are documented precisely because the drug has been studied: serious rash, hypersensitivity, psychiatric symptoms and cardiovascular cautions all sit on the FDA label.
Can I take bromantane and modafinil together?: Nothing in either report supports it. Both act on the dopamine transporter, and the bromantane report explicitly lists modafinil among the dopaminergics to use caution with, alongside methylphenidate, amphetamines, L-DOPA and selegiline. There is no combination data on either side. Run one, judge it inside its own window, then decide.
Which one is cheaper?: Neither, in any way that should sway you. Bromantane runs an estimated $12 to $30 a month at 30 mg on about 10 mornings, and modafinil an estimated $18 to $35 a month for generic 200 mg tablets with a coupon. Both are estimates priced 2026-09-07. Modafinil adds a prescribing visit, bromantane adds a third-party HPLC assay.
Can I compete in tested sport on either one?: No. Bromantane has been on the WADA prohibited list under S6.A stimulants every year since 1997, and Western awareness of the compound arrived through the Atlanta 1996 doping cases documented in Burnat 1997. Modafinil is prohibited in competition under the same S6.A category. Both reports list tested sport as a contraindication.
Who should avoid these?: Both rule out pregnancy and lactation, and bromantane adds an age floor of 18, MAOI co-administration, bipolar I disorder and uncontrolled hypertension.Modafinil rules out a history of serious drug rash, mania or psychosis, uncontrolled anxiety, arrhythmia or significant cardiovascular disease, left ventricular hypertrophy, mitral valve prolapse, uncontrolled hypertension and severe hepatic impairment, and it needs backup contraception alongside hormonal birth control.

Evidence Sources

RCT Treatment of asthenic disorders in patients with psychoautonomic syndrome (2010) Russian Phase III multicenter trial, n=728 outpatients at 50 to 100 mg a day for 28 days. CGI-S responder 76.0 percent, adverse events 3 percent, discontinuation 0.8 percent.
RCT Ladasten in the treatment of neurasthenia, a placebo-controlled comparative study (2009) The only published placebo-controlled bromantane RCT. 28 days plus a one-week washout, with no withdrawal syndrome.
Animal study Cytosine demethylation in the TH gene promoter in hypothalamic cells under the action of ladasten (2006) Epigenetic activation of tyrosine hydroxylase transcription, the strongest mechanistic finding on the bromantane side.
Animal study Effects of ladasten on dopaminergic neurotransmission and hippocampal synaptic plasticity in rats (2007) D1 and D5 dependent hippocampal LTP transformation. The only bromantane mechanism paper placed in a Western journal.
RCT Characteristics of ladasten effect in neurasthenia patients with various EEG parameters (2008) EEG-stratified responder analysis showing a dual profile: psychostimulant or anxiolytic depending on baseline alpha.
Observational Multi-laboratory European and Australian surveillance of illicit nootropics (2025) Bromantane detected in 2 illicit samples, one at 33.2 mg per unit. A concrete underdose datapoint from the gray-market channel.
Meta-analysis An updated systematic review and meta-analysis of modafinil for excessive daytime sleepiness in narcolepsy (2026) Five studies, n=997. Maintenance of wakefulness mean difference +3.56 minutes and Epworth mean difference -3.34. No eligible new randomized trials after 2017.
Systematic review Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review (2015) Cautious support for complex attention, executive function and learning in healthy rested adults, with inconsistent domains.
RCT Modafinil for sustaining alertness and performance of aviators: a helicopter simulator study (2000) Double-blind placebo-controlled sleep-deprivation trial in pilots. Modafinil attenuated decrements in simulator performance and alertness.
RCT Modafinil's effects on simulator performance and mood in pilots during 37 hours without sleep (2004) Performance and mood during extended wakefulness. Relevant to sleep-deprivation rescue rather than daily use in rested adults.
RCT Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers (2013) A mixed cognitive profile with a creativity trade-off rather than uniform enhancement.
Observational Effects of modafinil on dopamine and dopamine transporters in the male human brain (2009) Human PET study confirming dopamine and dopamine transporter effects, which anchors both the mechanism and the abuse-liability discussion.
Meta-analysis Assessing condition-specific adverse event profiles of modafinil for labelled and off-label uses (2026) 54 studies. Adverse-effect signals differ by indication and include insomnia, anxiety, nausea, headache and decreased appetite.
Meta-analysis Efficacy and safety of modafinil in post-stroke fatigue: systematic review and meta-analysis (2026) Four studies, 1,001 participants. No significant overall improvement in post-stroke fatigue; a possible mental-fatigue signal judged very low certainty.
Guideline Treatment of central disorders of hypersomnolence clinical practice guideline, AASM (2021) Strong recommendation for modafinil in adult narcolepsy and adult idiopathic hypersomnia. It supports medical use, not nootropic use.
Label Modafinil tablets prescribing information, FDA DailyMed (2026) Official label covering indications, 200 mg dosing, serious rash, hypersensitivity, psychiatric and cardiovascular warnings, and drug interactions.
Guideline WADA 2025 Prohibited List (2025) Bromantane has appeared on S6.A stimulants on every annual list since 1997.

Glossary

Quick reference for the medical and technical terms used in this comparison.

TH Tyrosine Hydroxylase: The rate-limiting enzyme in dopamine production. Bromantane raises its gene expression by demethylating the promoter, which is what makes it upstream of a classical stimulant.
DAT Dopamine Transporter: The pump that clears dopamine back out of the synapse. Both compounds inhibit it weakly, which is why the reports advise against running them together.
CGI-S Clinical Global Impression, Severity: A clinician's overall rating of how ill a patient is. The responder rate on it was 76.0 percent in the 728-patient bromantane trial.
MWT Maintenance of Wakefulness Test: A lab measure of how long someone can stay awake in a quiet, dim room. Mann 2026 found a 3.56 minute gain on it with modafinil.
ESS Epworth Sleepiness Scale: An eight-item questionnaire scoring how likely you are to doze off in ordinary situations. Mann 2026 found a 3.34 point drop with modafinil.
BDNF Brain-Derived Neurotrophic Factor: A protein that supports the survival and growth of neurons. Salimgareeva 2012 found bromantane raises its messenger RNA along with NGF.
SJS Stevens-Johnson Syndrome: A rare, severe skin and mucous-membrane reaction. It appears on the modafinil FDA label and rules out anyone with a history of serious drug rash.
WADA World Anti-Doping Agency: The body that publishes the prohibited list for tested sport. Bromantane has been on it since 1997 and modafinil is prohibited in competition.
AASM American Academy of Sleep Medicine: The professional body whose 2021 guideline strongly recommends modafinil for adult narcolepsy and idiopathic hypersomnia.

Nick Urban Health Optimization Researcher & CHEK Holistic Lifestyle Coach Level 2

I've spent over a decade testing performance compounds on myself and screening them for clients and podcast guests

Reviewed Sep 7, 2026 · next review Dec 6, 2026

Find which one fits your biology

Take the BioHarmony Quiz